Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -227,313 | -124,014 | -65,220 | -290,581 | -215,320 |
| Depreciation Amortization | 7,722 | 6,269 | 3,706 | 17,341 | 12,815 |
| Accounts payable and accrued liabilities | 3,989 | 2,087 | 1,248 | 3,705 | 3,783 |
| Other Working Capital | -24,685 | -45,725 | -35,957 | -20,412 | -4,351 |
| Other Operating Activity | 68,234 | 46,376 | 24,114 | 78,558 | 57,178 |
| Operating Cash Flow | $-172,053 | $-115,007 | $-72,109 | $-211,389 | $-145,895 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,984 | -6,934 | -4,041 | -8,500 | -5,447 |
| Purchase Of Investment | -628,330 | -505,460 | -364,337 | -1,422,938 | -1,191,491 |
| Sale Of Investment | 627,486 | 483,147 | 250,500 | 1,409,812 | 1,216,062 |
| Investing Cash Flow | $-13,828 | $-29,247 | $-117,878 | $-21,626 | $19,124 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,019 | 5,865 | 1,463 | 19,348 | 14,180 |
| Financing Cash Flow | $11,019 | $5,865 | $1,463 | $19,348 | $14,180 |
| Beginning Cash Position | 294,977 | 294,977 | 294,977 | 508,644 | 508,644 |
| End Cash Position | 120,115 | 156,588 | 106,453 | 294,977 | 396,053 |
| Net Cash Flow | $-174,862 | $-138,389 | $-188,524 | $-213,667 | $-112,591 |
| Free Cash Flow | |||||
| Operating Cash Flow | -172,053 | -115,007 | -72,109 | -211,389 | -145,895 |
| Capital Expenditure | -12,984 | -6,934 | -4,041 | -8,500 | -5,447 |
| Free Cash Flow | -185,037 | -121,941 | -76,150 | -219,889 | -151,342 |